Clinical Trial Update: A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL

View source ↗

Summary

A multicenter prospective real-world study evaluating a tucidinostat-containing regimen as first-line treatment for diffuse large B-cell lymphoma; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Tucidinostat (tucidinostat)

Snippet

Sponsor: Ruijin Hospital | Conditions: DLBCL | Status: RECRUITING